Dimensional Fund Advisors LP Purchases 673,979 Shares of Sotera Health (NASDAQ:SHC)

Dimensional Fund Advisors LP increased its position in Sotera Health (NASDAQ:SHC - Free Report) by 27.3% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 3,143,955 shares of the company's stock after purchasing an additional 673,979 shares during the quarter. Dimensional Fund Advisors LP owned 1.11% of Sotera Health worth $43,004,000 as of its most recent filing with the Securities and Exchange Commission.

Several other hedge funds and other institutional investors have also recently added to or reduced their stakes in the company. Xponance Inc. raised its stake in Sotera Health by 6.0% during the fourth quarter. Xponance Inc. now owns 17,495 shares of the company's stock valued at $239,000 after buying an additional 989 shares in the last quarter. Wealth Enhancement Advisory Services LLC raised its stake in shares of Sotera Health by 2.1% during the fourth quarter. Wealth Enhancement Advisory Services LLC now owns 51,940 shares of the company's stock valued at $711,000 after purchasing an additional 1,047 shares in the last quarter. GAMMA Investing LLC raised its holdings in Sotera Health by 37.5% during the fourth quarter. GAMMA Investing LLC now owns 4,109 shares of the company's stock worth $56,000 after purchasing an additional 1,121 shares in the last quarter. Blue Trust Inc. lifted its holdings in Sotera Health by 164.3% in the 4th quarter. Blue Trust Inc. now owns 1,834 shares of the company's stock valued at $25,000 after acquiring an additional 1,140 shares during the last quarter. Finally, Bank of Montreal Can grew its position in Sotera Health by 10.6% in the fourth quarter. Bank of Montreal Can now owns 18,184 shares of the company's stock worth $249,000 after buying an additional 1,740 shares during the last quarter. Hedge funds and other institutional investors own 91.03% of the company's stock.

Sotera Health Stock Down 0.1 %

NASDAQ SHC traded down $0.01 on Friday, reaching $13.22. The stock had a trading volume of 200,945 shares, compared to its average volume of 1,205,884. The company has a current ratio of 2.88, a quick ratio of 2.61 and a debt-to-equity ratio of 4.91. Sotera Health has a 1 year low of $9.53 and a 1 year high of $17.08. The business has a 50 day moving average price of $11.42 and a 200 day moving average price of $12.97. The company has a market capitalization of $3.75 billion, a price-to-earnings ratio of 52.88 and a beta of 1.88.

Sotera Health (NASDAQ:SHC - Get Free Report) last released its quarterly earnings data on Thursday, May 1st. The company reported $0.14 EPS for the quarter, topping analysts' consensus estimates of $0.12 by $0.02. The firm had revenue of $254.52 million for the quarter, compared to the consensus estimate of $245.56 million. Sotera Health had a return on equity of 42.27% and a net margin of 6.31%. The firm's revenue was up 2.6% on a year-over-year basis. During the same quarter in the prior year, the company posted $0.13 earnings per share. On average, analysts forecast that Sotera Health will post 0.61 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

SHC has been the subject of several recent analyst reports. The Goldman Sachs Group upgraded shares of Sotera Health from a "neutral" rating to a "buy" rating and raised their target price for the stock from $14.00 to $17.00 in a report on Monday. Piper Sandler reduced their target price on Sotera Health from $15.00 to $13.00 and set a "neutral" rating for the company in a report on Wednesday, April 23rd. Finally, Barclays lowered their price target on Sotera Health from $16.00 to $12.00 and set an "overweight" rating on the stock in a report on Thursday, April 10th. One equities research analyst has rated the stock with a hold rating and four have assigned a buy rating to the company. According to MarketBeat.com, the stock currently has an average rating of "Moderate Buy" and an average target price of $15.80.

Sotera Health Profile

Sotera Health Company engages in the provision of sterilization, lab testing, and advisory services in the United States and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. It provides mission-critical end-to-end sterilization services, including gamma and electron beam irradiation, and ethylene oxide processing, as well as designs, installs, and maintains gamma irradiation systems.